Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 1010 for “"leukaemia"”.
-
Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
… and is a common treatment for acute myeloid leukaemia (AML). Allo-SCT relies on donor T cells identifying AML cells as foreign and eradicating them, which is known as graft-versus-leukaemia (GvL). Donor T cells recognise AML through interactions between their T cell receptor (TCR) and peptide …
-
Features of leukaemia
Typewritten
-
Identifying the DNA binding specificity of mixed lineage leukaemia in leukaemia
… an aggressive, poor-prognosis subset of acute leukaemia. Although MLL binds unmethylated CpG-island promoters through its CXXC domain, only a subset of these potential sites is occupied in the fusion context. This thesis investigates the determinants of that selectivity across three regulatory …
-
Endogenous Feline Leukaemia Viruses: Their Role in Leukaemia and Resistance to Infection
This investigation was designed to characterise the expression of enFeLV in vitro and in vivo at both RNA and protein levels in feline cells and tissues because of the potential importance of endogenous virus expression in mediating resistance to infection and participating in genetic …
-
Leucosis (leukaemia) in childhood
… Virchow described this disease and called it leukaemia. He differentiated between a splenic leukaemia in which the principle pathological change was in the spleen and a lymphatic leukaemia in which the lymph glands were primarily involved. In 1857 Von Friedrich described the first case of …
-
Induction of Graft-Versus-Leukaemia Activity Following Bone Marrow Transplantation for Chronic Myeloid Leukaemia
… describes the induction of in vitro graft-versus-leukaemia (GVL) activity following bone marrow transplantation (BMT) for chronic myeloid leukaemia (CML).
-
Radio-Active Phosphorus in Leukaemia
… is concerned with the response to P32 of chronic leukaemia in humans. Section I outlines the historical basis of classification of the leukaemias, preference being given for a simple working system. The common clinical syndromes are described, followed by a brief account of the main clinical …
-
Feline leukaemia virus-specific proteins
… was concerned with the polypeptides of feline leukaemia virus (FeLV), both the structural polypeptides of the virus particle and putative non-structural proteins which appear in FeLV-infected and transformed cells. In the first part of the work (Chapter Two) it was established that virus …
-
Redox signalling in myeloid leukaemia
… expressed in approximately 90% of acute myeloid leukaemia (AML) patients. Internal tandem duplication of sequences in the juxtamembrane domain of the FLT3 receptor (FLT3-ITD) is the most prevalent FLT3 mutation accounting for 15-35% of AML cases. FLT3-ITD expressing cells produce elevated levels …
-
The early stages of leukaemia
… has been a growing literature on the subject of leukaemia in its earlier stages, and it is becoming apparent that conditions formerly thought to be separate entities, are actually unusual manifestations of a well recognised type. Thus the classification and nomenclature tends to become …
-
Isolation and characterisation of inhibitors of leukaemia with translocatins involving the mixed lineage leukaemia oncogene
Acute lymphoblastic leukaemia is the most common childhood cancer with cure rates of approximately 80%. This success can be attributed to the introduction of risk stratification for patients and employment of intensified treatment regimes for patients with high risk disease. However, the …
-
Precision medicine in chronic myeloid leukaemia
… revolutionized the landscape of chronic myeloid leukaemia (CML) therapy and overall survival over the past two decades has dramatically improved, but outcomes remain heterogenous. This thesis demonstrates the importance of exploratory biomarkers for the prediction of the spectrum of responses in …
-
A study of chromosomes in leukaemia
[Typewritten]
-
Polarised secretion of leukaemia inhibitory factor
Leukaemia inhibitory factor (LIF) is a cytokine that is active on a wide variety of cells. Multiple LIF transcripts have been described. The transcripts LIF-D and LIF-M encode different signal peptides, which in mouse have been associated with differential localisation of the mature protein. LIF-D …
-
Parthenolide derivatives as potential leukaemia drugs
Chronic lymphocytic leukaemia (CLL) is a common type of leukaemia and it is frequently diagnosed in Western countries. Current therapy to cure this frequently diagnosed leukaemia is unsatisfactory. Therefore, the search for potential drugs has become an important research topic in recent years. …
-
Proteasome inhibition in chronic myeloid leukaemia
CML is treated effectively with TKI, however two key problems remain - the insensitivity of CM HSC to TKI and the emergence of TKI-resistant BCR-ABL mutations. BCR-ABL activity is associated with increased proteasome activity and PI are cytotoxic against CML cell lines. We demonstrate that …
-
Isoellipticines: novel compounds for leukaemia treatment
… a number of different cell types, particularly leukaemia cell lines. We consequently examined the effect of these derivatives in detail on the Acute Myeloid Leukaemia (AML) cell line, MV4-11. Cell cycle analyses revealed that the compounds had a range of distinctive cell cycle effects on MV4-11 …
-
Study of the chemotherapy of leukaemia
… disease one hundred years ago, the treatment of leukaemia has passed through two main phases. During the first fifty years treatment was by chemical agents. A ,large variety underwent clinical trial and some were found to temporarily influence the leukaemic process. Unfortunately many were highly …
-
Graft-versus-leukaemia antigen discovery utilising the bone marrow T cell repertoire in patients with acute myeloid leukaemia
Acute myeloid leukaemia (AML) is a highly aggressive haematological malignancy for which allogeneic stem cell transplantation (alloSCT) remains the most effective curative therapy. Durable disease control relies on the graft-versus-leukaemia (GvL) effect, where donor-derived T cells eradicate …
Page 1 of 51